These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1370678)
41. Two cases of recessive dystrophic epidermolysis bullosa diagnosed as severe generalized. Ohashi M; Shu E; Nagai M; Murase K; Nakano H; Tamai K; Sawamura D; Hiroka T; Seishima M; Kitajima Y; Aoyama Y J Dermatol; 2011 Sep; 38(9):893-9. PubMed ID: 21658117 [TBL] [Abstract][Full Text] [Related]
42. Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblasts. Gardella R; Zoppi N; Ferraboli S; Marini D; Tadini G; Barlati S; Colombi M Hum Mutat; 1999; 13(6):439-52. PubMed ID: 10408773 [TBL] [Abstract][Full Text] [Related]
43. A case of pretibial dystrophic epidermolysis bullosa: decreased expression of the non-helical domain of type VII collagen molecule. Horiguchi Y; Leigh IM; Oguchi M; Tanaka T; Imamura S J Dermatol; 1993 Feb; 20(2):79-84. PubMed ID: 8478490 [TBL] [Abstract][Full Text] [Related]
44. Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Heagerty AH; Kennedy AR; Leigh IM; Purkis P; Eady RA Br J Dermatol; 1986 Aug; 115(2):125-31. PubMed ID: 3527251 [TBL] [Abstract][Full Text] [Related]
45. Premature termination codon mutations in the type VII collagen gene in recessive dystrophic epidermolysis bullosa result in nonsense-mediated mRNA decay and absence of functional protein. Christiano AM; Amano S; Eichenfield LF; Burgeson RE; Uitto J J Invest Dermatol; 1997 Sep; 109(3):390-4. PubMed ID: 9284110 [TBL] [Abstract][Full Text] [Related]
46. The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa. Rusenko KW; Gammon WR; Fine JD; Briggaman RA J Invest Dermatol; 1989 Apr; 92(4):623-7. PubMed ID: 2649597 [TBL] [Abstract][Full Text] [Related]
48. Three new cases of transient bullous dermolysis of the newborn. Hanson SG; Fine JD; Levy ML J Am Acad Dermatol; 1999 Mar; 40(3):471-6. PubMed ID: 10071321 [TBL] [Abstract][Full Text] [Related]
49. Update on the pathogenesis of squamous cell carcinoma development in recessive dystrophic epidermolysis bullosa. Kim M; Murrell DF Eur J Dermatol; 2015 Apr; 25 Suppl 1():30-2. PubMed ID: 26083672 [TBL] [Abstract][Full Text] [Related]
51. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561 [TBL] [Abstract][Full Text] [Related]
52. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa. Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200 [TBL] [Abstract][Full Text] [Related]
53. Premature termination codons on both alleles of the type VII collagen gene (COL7A1) in three brothers with recessive dystrophic epidermolysis bullosa. Christiano AM; Suga Y; Greenspan DS; Ogawa H; Uitto J J Clin Invest; 1995 Mar; 95(3):1328-34. PubMed ID: 7883979 [TBL] [Abstract][Full Text] [Related]
54. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228 [TBL] [Abstract][Full Text] [Related]
57. Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Siprashvili Z; Nguyen NT; Bezchinsky MY; Marinkovich MP; Lane AT; Khavari PA Hum Gene Ther; 2010 Oct; 21(10):1299-310. PubMed ID: 20497034 [TBL] [Abstract][Full Text] [Related]
58. An RNA-targeted therapy for dystrophic epidermolysis bullosa. Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459 [TBL] [Abstract][Full Text] [Related]
59. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548 [TBL] [Abstract][Full Text] [Related]
60. Normal molecular weight of type VII collagen produced by recessive dystrophic epidermolysis bullosa keratinocytes. Jenison M; Fine JD; Gammon WR; O'Keefe EJ J Invest Dermatol; 1993 Jan; 100(1):93-6. PubMed ID: 8423408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]